

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 5.45232716 |
| 2 | positive regulation of heat generation (GO:0031652) | 5.42760564 |
| 3 | regulation of fever generation (GO:0031620) | 5.40363586 |
| 4 | positive regulation of chemokine biosynthetic process (GO:0045080) | 5.09669498 |
| 5 | neutrophil activation involved in immune response (GO:0002283) | 4.76183056 |
| 6 | response to peptidoglycan (GO:0032494) | 4.67936804 |
| 7 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.32614498 |
| 8 | regulation of chemokine biosynthetic process (GO:0045073) | 4.27344816 |
| 9 | regulation of heat generation (GO:0031650) | 4.25048560 |
| 10 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.14782329 |
| 11 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.12091321 |
| 12 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.12091321 |
| 13 | modulation by symbiont of host immune response (GO:0052553) | 4.12091321 |
| 14 | positive regulation by symbiont of host defense response (GO:0052509) | 4.12091321 |
| 15 | modulation by symbiont of host defense response (GO:0052031) | 4.12091321 |
| 16 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.12091321 |
| 17 | eosinophil chemotaxis (GO:0048245) | 4.11205923 |
| 18 | detection of molecule of bacterial origin (GO:0032490) | 4.06524955 |
| 19 | regulation of mononuclear cell migration (GO:0071675) | 4.03323627 |
| 20 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.95086207 |
| 21 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.92903281 |
| 22 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.90732547 |
| 23 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.85530702 |
| 24 | granulocyte activation (GO:0036230) | 3.84647743 |
| 25 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.80525204 |
| 26 | superoxide anion generation (GO:0042554) | 3.71447666 |
| 27 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 3.70831433 |
| 28 | cellular response to zinc ion (GO:0071294) | 3.69702440 |
| 29 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.69027879 |
| 30 | monocyte chemotaxis (GO:0002548) | 3.66248558 |
| 31 | NIK/NF-kappaB signaling (GO:0038061) | 3.63931279 |
| 32 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.62154072 |
| 33 | reactive oxygen species biosynthetic process (GO:1903409) | 3.61428829 |
| 34 | eosinophil migration (GO:0072677) | 3.57229445 |
| 35 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.48176250 |
| 36 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.47081704 |
| 37 | regulation of vitamin metabolic process (GO:0030656) | 3.46770930 |
| 38 | regulation of macrophage cytokine production (GO:0010935) | 3.46379487 |
| 39 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.45720664 |
| 40 | wound healing, spreading of epidermal cells (GO:0035313) | 3.42099883 |
| 41 | positive regulation of type 2 immune response (GO:0002830) | 3.41948720 |
| 42 | neutrophil activation (GO:0042119) | 3.41785612 |
| 43 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.39316520 |
| 44 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.35714036 |
| 45 | cellular response to lipopolysaccharide (GO:0071222) | 3.35332837 |
| 46 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.31362170 |
| 47 | positive regulation of interleukin-6 production (GO:0032755) | 3.30976687 |
| 48 | response to muramyl dipeptide (GO:0032495) | 3.28365517 |
| 49 | macrophage activation involved in immune response (GO:0002281) | 3.27693067 |
| 50 | positive regulation of macrophage cytokine production (GO:0060907) | 3.26071114 |
| 51 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.23030706 |
| 52 | cellular response to molecule of bacterial origin (GO:0071219) | 3.22399812 |
| 53 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.20079525 |
| 54 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.18737208 |
| 55 | positive regulation of acute inflammatory response (GO:0002675) | 3.16876582 |
| 56 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.16827974 |
| 57 | negative regulation of lipid storage (GO:0010888) | 3.15745784 |
| 58 | respiratory burst (GO:0045730) | 3.15647695 |
| 59 | response to protozoan (GO:0001562) | 3.15313749 |
| 60 | negative regulation of interleukin-17 production (GO:0032700) | 3.14239523 |
| 61 | regulation of nitric oxide biosynthetic process (GO:0045428) | 3.13927891 |
| 62 | positive regulation of chemokine production (GO:0032722) | 3.13882765 |
| 63 | oligosaccharide catabolic process (GO:0009313) | 3.13805841 |
| 64 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.13066925 |
| 65 | decidualization (GO:0046697) | 3.10677341 |
| 66 | regulation of macrophage chemotaxis (GO:0010758) | 3.09885385 |
| 67 | immunoglobulin mediated immune response (GO:0016064) | 3.09076035 |
| 68 | regulation of immunoglobulin secretion (GO:0051023) | 3.08759755 |
| 69 | regulation of podosome assembly (GO:0071801) | 3.07737145 |
| 70 | regulation of vascular endothelial growth factor production (GO:0010574) | 3.06980811 |
| 71 | response to host immune response (GO:0052572) | 3.04792198 |
| 72 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.04792198 |
| 73 | cellular response to nicotine (GO:0071316) | 3.04764532 |
| 74 | detection of external biotic stimulus (GO:0098581) | 3.02609957 |
| 75 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.00619773 |
| 76 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.00345618 |
| 77 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.98780967 |
| 78 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.98154544 |
| 79 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.96300896 |
| 80 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.95633074 |
| 81 | germinal center formation (GO:0002467) | 2.94434095 |
| 82 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.93046003 |
| 83 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.92563280 |
| 84 | cell adhesion mediated by integrin (GO:0033627) | 2.92328076 |
| 85 | positive regulation of transcription factor import into nucleus (GO:0042993) | 2.91918755 |
| 86 | glial cell migration (GO:0008347) | 2.90567232 |
| 87 | positive regulation of lymphocyte migration (GO:2000403) | 2.90377290 |
| 88 | negative regulation of interleukin-12 production (GO:0032695) | 2.90083067 |
| 89 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.90046763 |
| 90 | positive regulation vascular endothelial growth factor production (GO:0010575) | 2.86527838 |
| 91 | neutrophil migration (GO:1990266) | 2.84462514 |
| 92 | T-helper 1 type immune response (GO:0042088) | 2.83022382 |
| 93 | positive regulation of interferon-alpha production (GO:0032727) | 2.82882923 |
| 94 | defense response to protozoan (GO:0042832) | 2.82822525 |
| 95 | chronic inflammatory response (GO:0002544) | 2.79370752 |
| 96 | cellular response to biotic stimulus (GO:0071216) | 2.79188067 |
| 97 | opsonization (GO:0008228) | 2.78184538 |
| 98 | response to manganese ion (GO:0010042) | 2.78147169 |
| 99 | detection of biotic stimulus (GO:0009595) | 2.77986995 |
| 100 | granulocyte chemotaxis (GO:0071621) | 2.77168371 |
| 101 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.76349669 |
| 102 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.74670893 |
| 103 | cellular extravasation (GO:0045123) | 2.73311397 |
| 104 | detection of other organism (GO:0098543) | 2.72760144 |
| 105 | positive regulation of humoral immune response (GO:0002922) | 2.72396808 |
| 106 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.71394916 |
| 107 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.71214550 |
| 108 | positive regulation of mast cell degranulation (GO:0043306) | 2.71214550 |
| 109 | regulation of interleukin-6 production (GO:0032675) | 2.70838536 |
| 110 | response to host defenses (GO:0052200) | 2.70723995 |
| 111 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.70723995 |
| 112 | response to host (GO:0075136) | 2.70723995 |
| 113 | regulation of interferon-alpha production (GO:0032647) | 2.70671470 |
| 114 | macrophage activation (GO:0042116) | 2.70447856 |
| 115 | low-density lipoprotein particle clearance (GO:0034383) | 2.69695623 |
| 116 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.69523223 |
| 117 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.68700904 |
| 118 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.68484292 |
| 119 | regulation of chronic inflammatory response (GO:0002676) | 2.68301769 |
| 120 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.68267054 |
| 121 | cellular response to type I interferon (GO:0071357) | 2.67773718 |
| 122 | type I interferon signaling pathway (GO:0060337) | 2.67773718 |
| 123 | protein localization to endosome (GO:0036010) | 2.67245346 |
| 124 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.66830754 |
| 125 | neutrophil chemotaxis (GO:0030593) | 2.65387679 |
| 126 | cellular response to ethanol (GO:0071361) | 2.65114909 |
| 127 | positive regulation of leukocyte migration (GO:0002687) | 2.64686486 |
| 128 | response to type I interferon (GO:0034340) | 2.64676163 |
| 129 | granulocyte migration (GO:0097530) | 2.64238933 |
| 130 | activation of MAPKKK activity (GO:0000185) | 2.64214345 |
| 131 | regulation of prostaglandin secretion (GO:0032306) | 2.63044813 |
| 132 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.62390548 |
| 133 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.61923788 |
| 134 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.61093389 |
| 135 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.60987508 |
| 136 | lymphocyte chemotaxis (GO:0048247) | 2.59366486 |
| 137 | negative regulation of glucose transport (GO:0010829) | 2.58911075 |
| 138 | regulation of type 2 immune response (GO:0002828) | 2.58895736 |
| 139 | cellular response to arsenic-containing substance (GO:0071243) | 2.57653624 |
| 140 | myeloid dendritic cell differentiation (GO:0043011) | 2.57486987 |
| 141 | glycosphingolipid catabolic process (GO:0046479) | 2.55920704 |
| 142 | positive regulation of leukocyte chemotaxis (GO:0002690) | 2.54192580 |
| 143 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.51761187 |
| 144 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.51735324 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.86240974 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.51289445 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.27297710 |
| 4 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.75952239 |
| 5 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.71599975 |
| 6 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.69968298 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.49838209 |
| 8 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.06537292 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.02929152 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.76722086 |
| 11 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.74302713 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.73064518 |
| 13 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.72105973 |
| 14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.58114254 |
| 15 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.48571100 |
| 16 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.34977679 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.34962000 |
| 18 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.28636491 |
| 19 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.27307938 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.22261590 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.20531262 |
| 22 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.00196486 |
| 23 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 2.00158982 |
| 24 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 2.00158982 |
| 25 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.93229191 |
| 26 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.89736534 |
| 27 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.88042080 |
| 28 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.87472510 |
| 29 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.82425627 |
| 30 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.81273393 |
| 31 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.78929463 |
| 32 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.76764293 |
| 33 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.75058775 |
| 34 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.72808578 |
| 35 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.69918148 |
| 36 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.63041762 |
| 37 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.57910469 |
| 38 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.56663094 |
| 39 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.55247875 |
| 40 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.47558003 |
| 41 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.46923481 |
| 42 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.45986030 |
| 43 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.44445793 |
| 44 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.43337878 |
| 45 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.41484956 |
| 46 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.41042790 |
| 47 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.39620784 |
| 48 | SPI1_23127762_ChIP-Seq_K562_Human | 1.38484767 |
| 49 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.36863204 |
| 50 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.36612456 |
| 51 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.36612456 |
| 52 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.35922334 |
| 53 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.31755516 |
| 54 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.26228513 |
| 55 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.23355636 |
| 56 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.19439973 |
| 57 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.18461538 |
| 58 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.17463503 |
| 59 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.16424598 |
| 60 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.16033042 |
| 61 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.16010171 |
| 62 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.15290053 |
| 63 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.14457415 |
| 64 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14096379 |
| 65 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.13607465 |
| 66 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11907861 |
| 67 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11729549 |
| 68 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11251170 |
| 69 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.11023544 |
| 70 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10557252 |
| 71 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.09922011 |
| 72 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.09598774 |
| 73 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.07819934 |
| 74 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.07774100 |
| 75 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.06878623 |
| 76 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.06368701 |
| 77 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.06256499 |
| 78 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05121360 |
| 79 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.00745929 |
| 80 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.00158700 |
| 81 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98844367 |
| 82 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98167271 |
| 83 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.97562976 |
| 84 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.97125309 |
| 85 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95862305 |
| 86 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95468254 |
| 87 | ATF3_27146783_Chip-Seq_COLON_Human | 0.94786328 |
| 88 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.92259072 |
| 89 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.90165868 |
| 90 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.89827019 |
| 91 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.87681352 |
| 92 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.87505599 |
| 93 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.86464644 |
| 94 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86169545 |
| 95 | GATA1_19941826_ChIP-Seq_K562_Human | 0.84879097 |
| 96 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.84612240 |
| 97 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.84559380 |
| 98 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.84370897 |
| 99 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.83741478 |
| 100 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83119617 |
| 101 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.82707441 |
| 102 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.82557923 |
| 103 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.80648575 |
| 104 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.80593774 |
| 105 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.80303733 |
| 106 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.78817541 |
| 107 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.77651165 |
| 108 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.76493124 |
| 109 | MYB_26560356_Chip-Seq_TH2_Human | 0.76168768 |
| 110 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.75095568 |
| 111 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.75056347 |
| 112 | GATA3_26560356_Chip-Seq_TH2_Human | 0.73758587 |
| 113 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.73506239 |
| 114 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.72474981 |
| 115 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.72072099 |
| 116 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.71124088 |
| 117 | TP53_16413492_ChIP-PET_HCT116_Human | 0.70471850 |
| 118 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.70054550 |
| 119 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.69991630 |
| 120 | GATA2_19941826_ChIP-Seq_K562_Human | 0.69113266 |
| 121 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.68759817 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 4.63255702 |
| 2 | MP0003724_increased_susceptibility_to | 3.79293669 |
| 3 | MP0003436_decreased_susceptibility_to | 3.79145200 |
| 4 | MP0009785_altered_susceptibility_to | 3.35131767 |
| 5 | MP0003303_peritoneal_inflammation | 3.34724497 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 3.28940655 |
| 7 | MP0005503_abnormal_tendon_morphology | 3.27130179 |
| 8 | MP0006082_CNS_inflammation | 3.02168983 |
| 9 | MP0005275_abnormal_skin_tensile | 2.97279049 |
| 10 | MP0003300_gastrointestinal_ulcer | 2.94002630 |
| 11 | MP0001835_abnormal_antigen_presentation | 2.85511816 |
| 12 | MP0002419_abnormal_innate_immunity | 2.76830173 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.58368193 |
| 14 | MP0009764_decreased_sensitivity_to | 2.44862412 |
| 15 | MP0001533_abnormal_skeleton_physiology | 2.39254561 |
| 16 | MP0003075_altered_response_to | 2.31356725 |
| 17 | MP0005025_abnormal_response_to | 2.29043547 |
| 18 | MP0010368_abnormal_lymphatic_system | 2.27124084 |
| 19 | MP0005164_abnormal_response_to | 2.15053006 |
| 20 | MP0003705_abnormal_hypodermis_morpholog | 2.08250105 |
| 21 | MP0002139_abnormal_hepatobiliary_system | 1.93665573 |
| 22 | MP0003950_abnormal_plasma_membrane | 1.91866987 |
| 23 | MP0002998_abnormal_bone_remodeling | 1.85752042 |
| 24 | MP0005166_decreased_susceptibility_to | 1.83869074 |
| 25 | MP0002452_abnormal_antigen_presenting | 1.83567071 |
| 26 | MP0000343_altered_response_to | 1.83205057 |
| 27 | MP0003448_altered_tumor_morphology | 1.81743195 |
| 28 | MP0004947_skin_inflammation | 1.80362339 |
| 29 | MP0003279_aneurysm | 1.78467772 |
| 30 | MP0010352_gastrointestinal_tract_polyps | 1.78449794 |
| 31 | MP0003195_calcinosis | 1.77323195 |
| 32 | MP0008004_abnormal_stomach_pH | 1.75191787 |
| 33 | MP0005023_abnormal_wound_healing | 1.74547527 |
| 34 | MP0005390_skeleton_phenotype | 1.73373562 |
| 35 | MP0004510_myositis | 1.72524507 |
| 36 | MP0002723_abnormal_immune_serum | 1.71682819 |
| 37 | MP0005387_immune_system_phenotype | 1.66863065 |
| 38 | MP0001790_abnormal_immune_system | 1.66863065 |
| 39 | MP0002006_tumorigenesis | 1.63842114 |
| 40 | MP0000685_abnormal_immune_system | 1.63226226 |
| 41 | MP0005464_abnormal_platelet_physiology | 1.60970829 |
| 42 | MP0002933_joint_inflammation | 1.59913790 |
| 43 | MP0005451_abnormal_body_composition | 1.58959613 |
| 44 | MP0001845_abnormal_inflammatory_respons | 1.58385412 |
| 45 | MP0003806_abnormal_nucleotide_metabolis | 1.57147754 |
| 46 | MP0000858_altered_metastatic_potential | 1.56074996 |
| 47 | MP0002405_respiratory_system_inflammati | 1.55761840 |
| 48 | MP0001958_emphysema | 1.52791886 |
| 49 | MP0004883_abnormal_blood_vessel | 1.51392122 |
| 50 | MP0001853_heart_inflammation | 1.48600302 |
| 51 | MP0001800_abnormal_humoral_immune | 1.46655650 |
| 52 | MP0009278_abnormal_bone_marrow | 1.43007466 |
| 53 | MP0005671_abnormal_response_to | 1.42247216 |
| 54 | MP0001819_abnormal_immune_cell | 1.40338524 |
| 55 | MP0010155_abnormal_intestine_physiology | 1.38957921 |
| 56 | MP0005058_abnormal_lysosome_morphology | 1.38610008 |
| 57 | MP0002420_abnormal_adaptive_immunity | 1.38279423 |
| 58 | MP0003828_pulmonary_edema | 1.37100335 |
| 59 | MP0003656_abnormal_erythrocyte_physiolo | 1.36119290 |
| 60 | MP0003690_abnormal_glial_cell | 1.35328696 |
| 61 | MP0008469_abnormal_protein_level | 1.34328007 |
| 62 | MP0002295_abnormal_pulmonary_circulatio | 1.33394059 |
| 63 | MP0003186_abnormal_redox_activity | 1.29502912 |
| 64 | MP0005167_abnormal_blood-brain_barrier | 1.28433862 |
| 65 | MP0002060_abnormal_skin_morphology | 1.27842992 |
| 66 | MP0001879_abnormal_lymphatic_vessel | 1.27111920 |
| 67 | MP0002138_abnormal_hepatobiliary_system | 1.26522667 |
| 68 | MP0006054_spinal_hemorrhage | 1.19517237 |
| 69 | MP0005508_abnormal_skeleton_morphology | 1.10073439 |
| 70 | MP0005076_abnormal_cell_differentiation | 1.08168342 |
| 71 | MP0001542_abnormal_bone_strength | 1.07605411 |
| 72 | MP0002332_abnormal_exercise_endurance | 1.07581604 |
| 73 | MP0004272_abnormal_basement_membrane | 1.06805289 |
| 74 | MP0005310_abnormal_salivary_gland | 1.06595528 |
| 75 | MP0003795_abnormal_bone_structure | 1.05655494 |
| 76 | MP0003566_abnormal_cell_adhesion | 1.04147716 |
| 77 | MP0009765_abnormal_xenobiotic_induced | 1.03209440 |
| 78 | MP0005171_absent_coat_pigmentation | 1.02026692 |
| 79 | MP0001243_abnormal_dermal_layer | 1.00531961 |
| 80 | MP0003045_fibrosis | 1.00277528 |
| 81 | MP0001501_abnormal_sleep_pattern | 0.99321632 |
| 82 | MP0001851_eye_inflammation | 0.98045312 |
| 83 | MP0002254_reproductive_system_inflammat | 0.97619254 |
| 84 | MP0009763_increased_sensitivity_to | 0.91741785 |
| 85 | MP0003172_abnormal_lysosome_physiology | 0.91461242 |
| 86 | MP0001545_abnormal_hematopoietic_system | 0.89634217 |
| 87 | MP0005397_hematopoietic_system_phenotyp | 0.89634217 |
| 88 | MP0002282_abnormal_trachea_morphology | 0.88035239 |
| 89 | * MP0000249_abnormal_blood_vessel | 0.87787520 |
| 90 | MP0003091_abnormal_cell_migration | 0.87609842 |
| 91 | MP0003453_abnormal_keratinocyte_physiol | 0.86240515 |
| 92 | MP0008260_abnormal_autophagy | 0.85044240 |
| 93 | MP0004233_abnormal_muscle_weight | 0.84494795 |
| 94 | MP0008874_decreased_physiological_sensi | 0.82174554 |
| 95 | MP0001216_abnormal_epidermal_layer | 0.81814722 |
| 96 | MP0000767_abnormal_smooth_muscle | 0.81285328 |
| 97 | MP0000716_abnormal_immune_system | 0.81206390 |
| 98 | MP0005257_abnormal_intraocular_pressure | 0.80255450 |
| 99 | MP0000750_abnormal_muscle_regeneration | 0.79954483 |
| 100 | MP0001849_ear_inflammation | 0.77251277 |
| 101 | MP0005595_abnormal_vascular_smooth | 0.76987340 |
| 102 | MP0000604_amyloidosis | 0.76698449 |
| 103 | MP0002168_other_aberrant_phenotype | 0.75648715 |
| 104 | MP0002277_abnormal_respiratory_mucosa | 0.74546643 |
| 105 | MP0009840_abnormal_foam_cell | 0.72721474 |
| 106 | MP0004808_abnormal_hematopoietic_stem | 0.71305438 |
| 107 | MP0003191_abnormal_cellular_cholesterol | 0.70529106 |
| 108 | MP0000920_abnormal_myelination | 0.70387371 |
| 109 | MP0005165_increased_susceptibility_to | 0.68905443 |
| 110 | MP0001663_abnormal_digestive_system | 0.68572831 |
| 111 | MP0009333_abnormal_splenocyte_physiolog | 0.66247293 |
| 112 | MP0004782_abnormal_surfactant_physiolog | 0.65691571 |
| 113 | MP0005388_respiratory_system_phenotype | 0.65374088 |
| 114 | MP0002133_abnormal_respiratory_system | 0.65374088 |
| 115 | MP0008873_increased_physiological_sensi | 0.65166698 |
| 116 | MP0002896_abnormal_bone_mineralization | 0.65111342 |
| 117 | MP0000569_abnormal_digit_pigmentation | 0.65047513 |
| 118 | MP0002877_abnormal_melanocyte_morpholog | 0.62324704 |
| 119 | MP0002108_abnormal_muscle_morphology | 0.61685285 |
| 120 | MP0002113_abnormal_skeleton_development | 0.59859797 |
| 121 | MP0001873_stomach_inflammation | 0.57246098 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 6.69039841 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 6.69039841 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 6.69039841 |
| 4 | Eczematoid dermatitis (HP:0000976) | 6.31862589 |
| 5 | Recurrent abscess formation (HP:0002722) | 6.28943313 |
| 6 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.81036004 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 5.74192073 |
| 8 | Mediastinal lymphadenopathy (HP:0100721) | 4.81278455 |
| 9 | Abnormality of macrophages (HP:0004311) | 4.30424643 |
| 10 | Dysostosis multiplex (HP:0000943) | 4.19149523 |
| 11 | Gingivitis (HP:0000230) | 4.06432789 |
| 12 | Orchitis (HP:0100796) | 3.79809590 |
| 13 | Loss of speech (HP:0002371) | 3.75976612 |
| 14 | Neurofibrillary tangles (HP:0002185) | 3.73301024 |
| 15 | Systemic lupus erythematosus (HP:0002725) | 3.68803903 |
| 16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.54374437 |
| 17 | Stomatitis (HP:0010280) | 3.47209510 |
| 18 | Myositis (HP:0100614) | 3.42731560 |
| 19 | Vertebral compression fractures (HP:0002953) | 3.40847310 |
| 20 | Retrobulbar optic neuritis (HP:0100654) | 3.39614440 |
| 21 | Optic neuritis (HP:0100653) | 3.39614440 |
| 22 | Protrusio acetabuli (HP:0003179) | 3.33422106 |
| 23 | Premature rupture of membranes (HP:0001788) | 3.30301906 |
| 24 | Malnutrition (HP:0004395) | 3.27374535 |
| 25 | Recurrent skin infections (HP:0001581) | 3.26914007 |
| 26 | Nuclear cataract (HP:0100018) | 3.24751891 |
| 27 | Axonal loss (HP:0003447) | 3.22436616 |
| 28 | Mutism (HP:0002300) | 3.18046463 |
| 29 | Autoimmune thrombocytopenia (HP:0001973) | 3.16431936 |
| 30 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.14265207 |
| 31 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.14265207 |
| 32 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.14265207 |
| 33 | Myocardial infarction (HP:0001658) | 3.11600022 |
| 34 | Peritonitis (HP:0002586) | 3.11226848 |
| 35 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.11149036 |
| 36 | Osteolytic defects of the hand bones (HP:0009699) | 3.11149036 |
| 37 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.94794553 |
| 38 | Mucopolysacchariduria (HP:0008155) | 2.94794553 |
| 39 | Periodontitis (HP:0000704) | 2.94616756 |
| 40 | Glomerulonephritis (HP:0000099) | 2.87331123 |
| 41 | Cellulitis (HP:0100658) | 2.82448929 |
| 42 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.79085295 |
| 43 | Vasculitis (HP:0002633) | 2.73494763 |
| 44 | Abnormality of proline metabolism (HP:0010907) | 2.72247545 |
| 45 | Hydroxyprolinuria (HP:0003080) | 2.72247545 |
| 46 | Interstitial pulmonary disease (HP:0006530) | 2.71732842 |
| 47 | Increased IgM level (HP:0003496) | 2.65490652 |
| 48 | Thick nail (HP:0001805) | 2.65443492 |
| 49 | Pulmonary artery stenosis (HP:0004415) | 2.61431621 |
| 50 | Gingival bleeding (HP:0000225) | 2.59154428 |
| 51 | Obstructive lung disease (HP:0006536) | 2.58555646 |
| 52 | Chronic obstructive pulmonary disease (HP:0006510) | 2.58555646 |
| 53 | Neoplasm of head and neck (HP:0012288) | 2.58525826 |
| 54 | Esophageal neoplasm (HP:0100751) | 2.58525826 |
| 55 | Recurrent fungal infections (HP:0002841) | 2.58478153 |
| 56 | Metaphyseal irregularity (HP:0003025) | 2.57896467 |
| 57 | Cervical subluxation (HP:0003308) | 2.56287505 |
| 58 | Cerebral aneurysm (HP:0004944) | 2.55632922 |
| 59 | Cerebral inclusion bodies (HP:0100314) | 2.54211795 |
| 60 | Pulmonary infiltrates (HP:0002113) | 2.53050999 |
| 61 | Gastrointestinal infarctions (HP:0005244) | 2.50745275 |
| 62 | Progressive neurologic deterioration (HP:0002344) | 2.50052080 |
| 63 | Abnormality of the pericardium (HP:0001697) | 2.49919676 |
| 64 | Tetraparesis (HP:0002273) | 2.49295668 |
| 65 | Mitral stenosis (HP:0001718) | 2.47212024 |
| 66 | Basal ganglia calcification (HP:0002135) | 2.45179769 |
| 67 | Dilatation of the ascending aorta (HP:0005111) | 2.44921783 |
| 68 | Apathy (HP:0000741) | 2.43413390 |
| 69 | Nephritis (HP:0000123) | 2.43402462 |
| 70 | Alopecia of scalp (HP:0002293) | 2.42008467 |
| 71 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.41099419 |
| 72 | Aortic dissection (HP:0002647) | 2.39264805 |
| 73 | Vacuolated lymphocytes (HP:0001922) | 2.38960703 |
| 74 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.38658215 |
| 75 | Nausea (HP:0002018) | 2.35034103 |
| 76 | Diminished motivation (HP:0000745) | 2.34418401 |
| 77 | Abnormality of the nasal mucosa (HP:0000433) | 2.33219099 |
| 78 | Disinhibition (HP:0000734) | 2.30487624 |
| 79 | Prostate neoplasm (HP:0100787) | 2.30025317 |
| 80 | Increased cerebral lipofuscin (HP:0011813) | 2.28404874 |
| 81 | Hematochezia (HP:0002573) | 2.27024046 |
| 82 | Urticaria (HP:0001025) | 2.26075878 |
| 83 | Abnormality of complement system (HP:0005339) | 2.22265718 |
| 84 | Complement deficiency (HP:0004431) | 2.18497796 |
| 85 | Abnormality of iron homeostasis (HP:0011031) | 2.15016103 |
| 86 | Arterial thrombosis (HP:0004420) | 2.14222231 |
| 87 | Pustule (HP:0200039) | 2.10016557 |
| 88 | Premature loss of primary teeth (HP:0006323) | 2.08010112 |
| 89 | Neuronal loss in central nervous system (HP:0002529) | 2.07120227 |
| 90 | Thin bony cortex (HP:0002753) | 2.06305830 |
| 91 | Osteomyelitis (HP:0002754) | 2.06172811 |
| 92 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.06153085 |
| 93 | Keratoconjunctivitis sicca (HP:0001097) | 2.05936328 |
| 94 | Prolonged neonatal jaundice (HP:0006579) | 2.04455225 |
| 95 | Hemoptysis (HP:0002105) | 2.04413582 |
| 96 | Abnormality of the nasal septum (HP:0000419) | 2.03209716 |
| 97 | Recurrent pneumonia (HP:0006532) | 2.02710034 |
| 98 | Increased serum ferritin (HP:0003281) | 1.96246261 |
| 99 | Joint hemorrhage (HP:0005261) | 1.94465926 |
| 100 | Hemorrhage of the eye (HP:0011885) | 1.94326630 |
| 101 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.93993191 |
| 102 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.93688205 |
| 103 | Atrophic scars (HP:0001075) | 1.92403357 |
| 104 | Vascular tortuosity (HP:0004948) | 1.92315832 |
| 105 | Purpura (HP:0000979) | 1.91856111 |
| 106 | Recurrent lower respiratory tract infections (HP:0002783) | 1.90124546 |
| 107 | Soft skin (HP:0000977) | 1.88284869 |
| 108 | Parakeratosis (HP:0001036) | 1.86726454 |
| 109 | Autoimmune hemolytic anemia (HP:0001890) | 1.86682739 |
| 110 | Supranuclear gaze palsy (HP:0000605) | 1.85934197 |
| 111 | Thoracolumbar scoliosis (HP:0002944) | 1.85249460 |
| 112 | Esophageal varix (HP:0002040) | 1.85140647 |
| 113 | Keratoconjunctivitis (HP:0001096) | 1.84837056 |
| 114 | Cardiovascular calcification (HP:0011915) | 1.84801599 |
| 115 | Asymmetric septal hypertrophy (HP:0001670) | 1.84392793 |
| 116 | Bone pain (HP:0002653) | 1.84252289 |
| 117 | Broad metatarsal (HP:0001783) | 1.84238993 |
| 118 | Amyloidosis (HP:0011034) | 1.83689250 |
| 119 | Arterial tortuosity (HP:0005116) | 1.81976212 |
| 120 | Poor head control (HP:0002421) | 1.81940911 |
| 121 | Follicular hyperkeratosis (HP:0007502) | 1.81335058 |
| 122 | Femoral bowing (HP:0002980) | 1.81214163 |
| 123 | Submucous cleft hard palate (HP:0000176) | 1.80526830 |
| 124 | Mitral valve prolapse (HP:0001634) | 1.80317784 |
| 125 | Meningitis (HP:0001287) | 1.78239641 |
| 126 | Petechiae (HP:0000967) | 1.77969644 |
| 127 | Abnormality of the pleura (HP:0002103) | 1.77459129 |
| 128 | Spontaneous abortion (HP:0005268) | 1.75154880 |
| 129 | Arthralgia (HP:0002829) | 1.75090405 |
| 130 | Abnormality of the common coagulation pathway (HP:0010990) | 1.74847377 |
| 131 | Conjunctival telangiectasia (HP:0000524) | 1.73705689 |
| 132 | Upper motor neuron abnormality (HP:0002127) | 1.73652893 |
| 133 | Pathologic fracture (HP:0002756) | 1.73141982 |
| 134 | Recurrent viral infections (HP:0004429) | 1.72972369 |
| 135 | Flared iliac wings (HP:0002869) | 1.72211498 |
| 136 | Spondylolisthesis (HP:0003302) | 1.72070446 |
| 137 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.71712665 |
| 138 | Shallow orbits (HP:0000586) | 1.71330194 |
| 139 | Leukocytosis (HP:0001974) | 1.71317408 |
| 140 | Joint swelling (HP:0001386) | 1.70457790 |
| 141 | Nasal polyposis (HP:0100582) | 1.67849807 |
| 142 | Hepatosplenomegaly (HP:0001433) | 1.67123799 |
| 143 | Abnormality of the costochondral junction (HP:0000919) | 1.66347142 |
| 144 | Gangrene (HP:0100758) | 1.62894530 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 5.18566924 |
| 2 | MAP3K14 | 4.51550767 |
| 3 | PBK | 3.30747527 |
| 4 | BLK | 3.16880108 |
| 5 | TBK1 | 3.08490574 |
| 6 | ERN1 | 2.88701944 |
| 7 | TAOK2 | 2.75289818 |
| 8 | IRAK3 | 2.72712969 |
| 9 | PIM2 | 2.57303954 |
| 10 | GRK7 | 2.47046240 |
| 11 | IKBKB | 2.45125814 |
| 12 | STK24 | 2.24086339 |
| 13 | IRAK4 | 2.18150808 |
| 14 | LATS2 | 2.07690464 |
| 15 | IKBKE | 2.06697140 |
| 16 | BMPR2 | 2.06159714 |
| 17 | BMX | 1.88181854 |
| 18 | TXK | 1.85628854 |
| 19 | MAP3K3 | 1.77722642 |
| 20 | MST1R | 1.76812073 |
| 21 | DDR2 | 1.71491379 |
| 22 | EPHB2 | 1.71473385 |
| 23 | TAOK1 | 1.70981035 |
| 24 | ERBB4 | 1.70151179 |
| 25 | CHUK | 1.65065891 |
| 26 | JAK1 | 1.57248764 |
| 27 | ABL2 | 1.51439725 |
| 28 | JAK3 | 1.50427435 |
| 29 | EPHA2 | 1.50128597 |
| 30 | CDC42BPA | 1.49640857 |
| 31 | MAP3K12 | 1.45464068 |
| 32 | EPHA3 | 1.39564116 |
| 33 | RPS6KA4 | 1.38837924 |
| 34 | LMTK2 | 1.36585621 |
| 35 | ARAF | 1.35388870 |
| 36 | TYK2 | 1.34132429 |
| 37 | ERBB3 | 1.32187057 |
| 38 | PRPF4B | 1.28410722 |
| 39 | TGFBR2 | 1.27565553 |
| 40 | MST4 | 1.25982221 |
| 41 | ADRBK2 | 1.24909659 |
| 42 | PIM1 | 1.23106373 |
| 43 | BMPR1B | 1.20675340 |
| 44 | MAP3K13 | 1.19903740 |
| 45 | EPHB1 | 1.15405822 |
| 46 | CSK | 1.08342192 |
| 47 | MARK3 | 1.08016626 |
| 48 | EIF2AK2 | 1.06959719 |
| 49 | NME2 | 1.06191085 |
| 50 | STK38L | 1.02350385 |
| 51 | KIT | 0.98209556 |
| 52 | TRPM7 | 0.96702477 |
| 53 | RIPK1 | 0.94866284 |
| 54 | PDK2 | 0.93590193 |
| 55 | MAP4K1 | 0.92672658 |
| 56 | IRAK1 | 0.88822140 |
| 57 | JAK2 | 0.88534648 |
| 58 | ZAP70 | 0.85645745 |
| 59 | FGFR4 | 0.84987707 |
| 60 | ACVR1B | 0.84721988 |
| 61 | PAK4 | 0.83707245 |
| 62 | PDGFRB | 0.83660557 |
| 63 | MAP3K5 | 0.82306367 |
| 64 | YES1 | 0.81408110 |
| 65 | LYN | 0.81089494 |
| 66 | MAP3K11 | 0.79768991 |
| 67 | NLK | 0.76887903 |
| 68 | HCK | 0.75724310 |
| 69 | ABL1 | 0.75115059 |
| 70 | MAP3K9 | 0.73854603 |
| 71 | STK3 | 0.72940415 |
| 72 | PRKG2 | 0.72513347 |
| 73 | FGR | 0.69423096 |
| 74 | PRKCD | 0.68389783 |
| 75 | IRAK2 | 0.66667595 |
| 76 | KSR1 | 0.66043442 |
| 77 | LCK | 0.65143626 |
| 78 | PTK2 | 0.63546115 |
| 79 | KSR2 | 0.62967128 |
| 80 | STK10 | 0.62861453 |
| 81 | MAP3K1 | 0.62599888 |
| 82 | PDGFRA | 0.60982930 |
| 83 | NEK9 | 0.58689558 |
| 84 | MET | 0.58561476 |
| 85 | LRRK2 | 0.56556529 |
| 86 | TESK1 | 0.55925070 |
| 87 | MELK | 0.55479908 |
| 88 | TGFBR1 | 0.55265037 |
| 89 | EGFR | 0.54611002 |
| 90 | TTN | 0.53456514 |
| 91 | DAPK3 | 0.52995528 |
| 92 | SIK1 | 0.52548280 |
| 93 | CDK6 | 0.52341479 |
| 94 | FGFR3 | 0.52229000 |
| 95 | SYK | 0.51717672 |
| 96 | STK4 | 0.48740452 |
| 97 | MAP2K3 | 0.48125998 |
| 98 | GSK3A | 0.46108646 |
| 99 | ZAK | 0.45513702 |
| 100 | DYRK3 | 0.43435491 |
| 101 | PLK2 | 0.42931620 |
| 102 | INSR | 0.42694729 |
| 103 | PTK6 | 0.42446265 |
| 104 | MAP2K1 | 0.41223278 |
| 105 | TEC | 0.40269224 |
| 106 | CLK1 | 0.39049309 |
| 107 | RAF1 | 0.38799097 |
| 108 | BTK | 0.38604276 |
| 109 | MAP2K6 | 0.38489609 |
| 110 | TYRO3 | 0.37759746 |
| 111 | MATK | 0.37469425 |
| 112 | INSRR | 0.37258199 |
| 113 | LIMK1 | 0.36797921 |
| 114 | MOS | 0.36561220 |
| 115 | CSF1R | 0.36292615 |
| 116 | PIK3CG | 0.35839935 |
| 117 | MYLK | 0.35485771 |
| 118 | BCR | 0.33864143 |
| 119 | SIK3 | 0.33475095 |
| 120 | ERBB2 | 0.33083232 |
| 121 | DAPK2 | 0.31706087 |
| 122 | TAOK3 | 0.31082528 |
| 123 | IGF1R | 0.28960596 |
| 124 | MAPK4 | 0.28761030 |
| 125 | MAP2K2 | 0.27897243 |
| 126 | MAP3K2 | 0.27218557 |
| 127 | PRKCH | 0.26213518 |
| 128 | PRKCE | 0.26129138 |
| 129 | MAP3K8 | 0.25854806 |
| 130 | PKN1 | 0.24741178 |
| 131 | PDPK1 | 0.24191919 |
| 132 | ROCK1 | 0.22883711 |
| 133 | HIPK2 | 0.22252470 |
| 134 | CAMKK2 | 0.21140912 |
| 135 | MAPK7 | 0.19659970 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.04461571 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.53777145 |
| 3 | Malaria_Homo sapiens_hsa05144 | 3.22387546 |
| 4 | * Legionellosis_Homo sapiens_hsa05134 | 2.84726535 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.77675209 |
| 6 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.64810082 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.60626873 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.59841009 |
| 9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.55073750 |
| 10 | * NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.54394199 |
| 11 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.49378380 |
| 12 | Pertussis_Homo sapiens_hsa05133 | 2.47028761 |
| 13 | * TNF signaling pathway_Homo sapiens_hsa04668 | 2.45375411 |
| 14 | Allograft rejection_Homo sapiens_hsa05330 | 2.39166507 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.21085778 |
| 16 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.12379250 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.09051697 |
| 18 | * Salmonella infection_Homo sapiens_hsa05132 | 2.04423882 |
| 19 | Tuberculosis_Homo sapiens_hsa05152 | 2.04340908 |
| 20 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.99741061 |
| 21 | Asthma_Homo sapiens_hsa05310 | 1.91307767 |
| 22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.70121779 |
| 23 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.68619373 |
| 24 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.65709308 |
| 25 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.63441430 |
| 26 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.55213145 |
| 27 | Measles_Homo sapiens_hsa05162 | 1.52575396 |
| 28 | Influenza A_Homo sapiens_hsa05164 | 1.46889459 |
| 29 | Phagosome_Homo sapiens_hsa04145 | 1.43537753 |
| 30 | * Amoebiasis_Homo sapiens_hsa05146 | 1.40124209 |
| 31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.39088384 |
| 32 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.31425329 |
| 33 | Prion diseases_Homo sapiens_hsa05020 | 1.29296003 |
| 34 | Apoptosis_Homo sapiens_hsa04210 | 1.14657587 |
| 35 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.11123923 |
| 36 | Lysosome_Homo sapiens_hsa04142 | 1.05648580 |
| 37 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.03683753 |
| 38 | Shigellosis_Homo sapiens_hsa05131 | 0.96448144 |
| 39 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.90828976 |
| 40 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.88988304 |
| 41 | Hepatitis B_Homo sapiens_hsa05161 | 0.88815369 |
| 42 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.88662924 |
| 43 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.88597633 |
| 44 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.88164102 |
| 45 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.86756793 |
| 46 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.79529915 |
| 47 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.78841939 |
| 48 | * Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.78322466 |
| 49 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.73161071 |
| 50 | Hepatitis C_Homo sapiens_hsa05160 | 0.72122049 |
| 51 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.68995103 |
| 52 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.68853286 |
| 53 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.68376652 |
| 54 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.67596839 |
| 55 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.66129287 |
| 56 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.65085021 |
| 57 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.63626899 |
| 58 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.60430537 |
| 59 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.57154770 |
| 60 | Mineral absorption_Homo sapiens_hsa04978 | 0.56413185 |
| 61 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.56145627 |
| 62 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.56058844 |
| 63 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.55507851 |
| 64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.55338745 |
| 65 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.54544488 |
| 66 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.53532085 |
| 67 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.52514219 |
| 68 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.51652142 |
| 69 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.51108896 |
| 70 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.49585983 |
| 71 | Insulin resistance_Homo sapiens_hsa04931 | 0.49507526 |
| 72 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.48874254 |
| 73 | Viral myocarditis_Homo sapiens_hsa05416 | 0.48817737 |
| 74 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.48440140 |
| 75 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.48351592 |
| 76 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.47780841 |
| 77 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.46850646 |
| 78 | Focal adhesion_Homo sapiens_hsa04510 | 0.46791189 |
| 79 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45404322 |
| 80 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.44968753 |
| 81 | Platelet activation_Homo sapiens_hsa04611 | 0.44378601 |
| 82 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.42961005 |
| 83 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.42200280 |
| 84 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.40787595 |
| 85 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.40724365 |
| 86 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.39183008 |
| 87 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.38774665 |
| 88 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.36581079 |
| 89 | Other glycan degradation_Homo sapiens_hsa00511 | 0.35128175 |
| 90 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.34675817 |
| 91 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.33537323 |
| 92 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.32230180 |
| 93 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.32154255 |
| 94 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.31398046 |
| 95 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.31090577 |
| 96 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.31082507 |
| 97 | Adherens junction_Homo sapiens_hsa04520 | 0.30519361 |
| 98 | Galactose metabolism_Homo sapiens_hsa00052 | 0.30166689 |
| 99 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.29322782 |
| 100 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.28812332 |
| 101 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.27749125 |
| 102 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.27376886 |
| 103 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.27373915 |
| 104 | Endocytosis_Homo sapiens_hsa04144 | 0.26600704 |
| 105 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.26590348 |
| 106 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.25420833 |
| 107 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.25204515 |
| 108 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.24726455 |
| 109 | Retinol metabolism_Homo sapiens_hsa00830 | 0.24080983 |
| 110 | HTLV-I infection_Homo sapiens_hsa05166 | 0.24041974 |
| 111 | Bladder cancer_Homo sapiens_hsa05219 | 0.23390236 |
| 112 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.22729835 |
| 113 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.22239847 |
| 114 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.22109364 |
| 115 | Prostate cancer_Homo sapiens_hsa05215 | 0.20657637 |
| 116 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.18413787 |
| 117 | Pathways in cancer_Homo sapiens_hsa05200 | 0.17811338 |
| 118 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.16813603 |

